CEL-SCI Corporation (CVM) - Financial and Strategic SWOT Analysis Review

CEL-SCI Corporation (CVM) - Financial and Strategic SWOT Analysis Review


February 25, 2014
41 Pages - SKU: GBDT5210826
License type:
Online Download      US $125.00
Site License      US $250.00
Global Site License      US $375.00
CEL-SCI Corporation (CVM) - Financial and Strategic SWOT Analysis

Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

CEL-SCI Corporation (CEL-SCI) is a biotechnology company. It focuses on the research and development of immunotherapy products for the treatment of cancer and other diseases. The company’s lead investigational therapy is Multikine (Leukocyte Interleukin, Injection) currently in a global Phase III clinical trial. CEL-SCI is also investigating an immunotherapy (LEAPS-H1N1-DC) as a possible treatment for H1N1 hospitalized patients and as a vaccine (CEL-2000) for Rheumatoid Arthritis (currently in preclinical testing) using its LEAPS technology platform. Founded in 1983, the company has operations in Vienna, Virginia, and Baltimore, Maryland. CEL-SCI is headquartered in Vienna, Virginia, the US

CEL-SCI Corporation Key Recent Developments

Feb 11, 2014: CEL-SCI Reports First Quarter 2014 Financial Results
Feb 04, 2014: CEL-SCI Corporation Receives Approval for Listing and Trading of Warrants from the NYSE MKT under the Ticker Symbol “CVM WS”
Jan 02, 2014: CEL-SCI Reports Fiscal 2013 Financial Results and Clinical & Corporate Developments
Dec 05, 2013: NEW STORY CELSCI Receives Government Approval in Bosnia and Herzegovina to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer
Oct 18, 2013: CEL-SCI Regains Listing Compliance with NYSE MKT

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



More Pharmaceuticals Company reports by GlobalData

SPI Pharma, Inc. - Strategic SWOT Analysis Review by GlobalData
SPI Pharma, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains ...
Lupin Limited (LUPIN) - Financial and Strategic SWOT Analysis Review by GlobalData
Lupin Limited (LUPIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile ...
Heron Therapeutics, Inc. (HRTX) - Financial and Strategic SWOT Analysis Review by GlobalData
Heron Therapeutics, Inc. (HRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The ...
Ferring International Center S.A. - Strategic SWOT Analysis Review by GlobalData
Ferring International Center S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report ...
See all reports like this >>